Stepwise relationship between delay in percutaneous coronary intervention and long-term mortality in patients with

Kamil Bujak1, Mariusz Gąsior2, Mateusz Tajstra2

  • 13rd Department of Cardiology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland. kamil_bujak@o2.pl.

Kardiologia Polska
|June 4, 2023
PubMed

Insights

For non-ST-segment elevation myocardial infarction (NSTEMI) patients, longer door-to-percutaneous coronary intervention (PCI) times are linked to increased long-term mortality. This study confirms a stepwise relationship between delayed PCI and higher death rates at 12 and 36 months.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Clinical Research

Background:

  • Current guidelines advocate for timely coronary catheterization in non-ST-segment elevation myocardial infarction (NSTEMI) patients within 24 hours of admission.
  • The relationship between the timing of percutaneous coronary intervention (PCI) and long-term mortality in NSTEMI patients undergoing early invasive treatment remains unclear.

Purpose of the Study:

  • To investigate the association between door-to-PCI time and all-cause mortality at 12 and 36 months.
  • To analyze outcomes in NSTEMI patients treated with PCI within 24 hours at a PCI-capable center.

Main Methods:

  • Analysis of a nationwide registry of acute coronary syndromes (2007-2019) for NSTEMI patients.
  • Stratification into 12 groups based on 2-hour door-to-PCI time intervals.
  • Propensity score weighting with overlap weights to adjust for 33 confounding variables.

Main Results:

  • A total of 37,589 NSTEMI patients were included.
  • Increased 12-month and 36-month mortality rates were observed across consecutive door-to-PCI time intervals.
  • A significant positive correlation was found between time to PCI and mortality (rs = 0.61 for 12 months, rs = 0.65 for 36 months).

Conclusions:

  • Longer door-to-PCI times are associated with higher all-cause mortality rates at 12 and 36 months in NSTEMI patients.
  • The findings support the importance of minimizing delays in PCI for NSTEMI patients to improve long-term survival.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
33
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
13
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
11
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
22
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
11
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
205